Blackmores Limited is engaged in the development, sales and marketing of health products for humans and animals, including vitamins, herbal and mineral nutritional supplements. The Company's segments include Australia, China (in-country), Other Asia, BioCeuticals and Other. The Company offers over 250 vitamins, minerals, herbal and nutritional supplements. BioCeuticals is a provider of healthcare practitioner nutritional and therapeutic supplements. Its product categories include pet health; infant formula; superfoods; arthritis, joint, bone and muscle; brain health; cold, flu and immunity; digestive health; energy and exercise; eye health; everyday health; fish and nutritional oils; heart and circulation; men's health; nails, hair and skin; pregnancy and pre-conception; stress relief, and weight management. Its products include Acidophilus Bifidus, Alive! Men's 50+ Multivitamin, Alive! Women's 50+ Multivitamin, Alive! Women's Multivitamin and Bilberry Eyestrain Relief.
Industry, Sector and Symbol:
Average Prices:- 50 Day Moving Avg: A$92.63
- 200 Day Moving Avg: A$104.93
P/E:- Trailing P/E Ratio: 15.47
- P/E Growth: 0.00
Dividend:
Profitability:- Net Margins: 8.74%
- Return on Equity: 32.48%
- Return on Assets: 13.37%
Frequently Asked Questions for Blackmores Limited (ASX:BKL)
What is Blackmores Limited's stock symbol?
Blackmores Limited trades on the ASX under the ticker symbol "BKL."
Who are some of Blackmores Limited's key competitors?
Some companies that are related to Blackmores Limited include Adelaide Brighton (ABC), AGL Energy Ltd (AGL), AGL Energy Ltd (AGK), Alacer Gold Corp - CDI (AQG), ALS Ltd (ALQ), Alumina Limited (AWC), Amcor Limited (AMC), AMP Limited (AMP), Ansell Limited (ANN), APA Group (APA), Aquarius Platinum Limited (AQP), Ardent Leisure Group (AAD), Aristocrat Leisure Limited (ALL), Arrium Ltd (ARI), Asciano Ltd (AIO), ASX Ltd (ASX), Atlas Iron Limited (AGO) and Augend Ltd (TTN).
Who are Blackmores Limited's key executives?
Blackmores Limited's management team includes the folowing people:
- Marcus C. Blackmore, Executive Chairman of the Board, Interim Chief Executive Officer
- Christine Wendy Holgate, Chief Executive Officer, Managing Director, Executive Director
- Aaron Canning, Chief Financial Officer, Joint Co. Secretary
- Richard Henfrey, Chief Operating Officer
- Nathan A. Cheong, Managing Director - BioCeuticals
- David Fenlon, Managing Director - Australia & New Zealand
- Peter Osborne, Managing Director - Asia
- Lesley Braun, Director of Blackmores Institute
- Cecile Cooper, Company Secretary, Director - Corporate Affairs
- Stephen John Chapman, Lead Independent Non-Executive Deputy Chairman of the Board
MarketBeat Community Rating for Blackmores Limited (ASX BKL)MarketBeat's community ratings are surveys of what our community members think about Blackmores Limited and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Blackmores Limited (ASX:BKL) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for Blackmores Limited (ASX:BKL)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Blackmores Limited (ASX:BKL)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Blackmores Limited (ASX:BKL)No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Blackmores Limited (ASX:BKL)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Blackmores Limited (ASX:BKL)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Blackmores Limited (ASX:BKL)
Latest Headlines for Blackmores Limited (ASX:BKL)
| Source: |
|
